Retisert: profile and news






PSIVIDA QUARTERLY CASHFLOW - MARCH 2006 COMMENTARY AND HIGHLIGHTS  May 1, 2006
...a review of costs being undertaken and implemented during the period and the receipt of payments from collaborative partners and Retisert(TM) royalties. ... - Small Times

pSivida Limited: Rights Issue to Fund Late Stage Macular Edema ...  May 2, 2006
...products. Retisert(TM) is FDA approved for the treatment of uveitis. ... Retinitis. Bausch & Lomb own the trademarks; Vitrasert(R) and Retisert(TM). ... - TMCnet

pSivida to Present at UBS Global Specialty Pharmaceuticals ...  Apr 21, 2006
...pSivida has developed the only two FDA approved sustained release back of the eye treatments for chronic eye disease - Retisert(TM) and Vitrasert(R). Both ... - TMCnet

pSivida to raise $29m to fund clinical trials  May 2, 2006
...to the back of the eye, we believe the Medidurâ„¢ trials in DME will show a very similar improvement in visual acuity to that shown in the Retisertâ„¢ DME trial ... - WA Business News,


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org